Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens Feistritzer

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Memo|October 19, 2016
Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015Clemens Feistritzer, Stefan Schmidt
Blood|January 1, 2005
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivationClemens Feistritzer, Matthias Riewald
Memo|July 21, 2017
ASH Meeting 2016: developments in hemostaseologyClemens Feistritzer, Birgit Mosheimer
Expert Opinion on Biological Therapy|June 9, 2007
Effects of anticoagulant strategies on activation of inflammation and coagulationClemens Feistritzer, Christian J Wiedermann
Clinical Pharmacokinetics|March 17, 2012
Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studiesRomuald Bellmann, Clemens Feistritzer, Christian J Wiedermann
Neuroimmunomodulation|February 14, 2003
Neuropeptide-induced inhibition of IL-16 release from eosinophilsStefan Dunzendorfer, Clemens Feistritzer, Barbara Enrich, et al.
Blood|December 20, 2007
Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombinReto A Schuepbach, Clemens Feistritzer, Lawrence F Brass, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2022
High SARS-CoV-2 vaccination coverage but still room for improvement in patients with haemophila: A single-centre analysisFlorian Kocher, Andreas Seeber, Josia Fauser, et al.
BMC Ophthalmology|May 15, 2022
Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case reportJasmin Regensburger, Teresa Rauchegger, Lorin Loacker, et al.
Therapeutic Advances in Hematology|April 19, 2021
Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical proceduresFlorian Kocher, Andreas Seeber, Johannes Kerschbaumer, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Memo|October 19, 2016
Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015Clemens Feistritzer, Stefan Schmidt
Blood|January 1, 2005
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivationClemens Feistritzer, Matthias Riewald
Memo|July 21, 2017
ASH Meeting 2016: developments in hemostaseologyClemens Feistritzer, Birgit Mosheimer
Expert Opinion on Biological Therapy|June 9, 2007
Effects of anticoagulant strategies on activation of inflammation and coagulationClemens Feistritzer, Christian J Wiedermann
Clinical Pharmacokinetics|March 17, 2012
Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studiesRomuald Bellmann, Clemens Feistritzer, Christian J Wiedermann
Neuroimmunomodulation|February 14, 2003
Neuropeptide-induced inhibition of IL-16 release from eosinophilsStefan Dunzendorfer, Clemens Feistritzer, Barbara Enrich, et al.
Blood|December 20, 2007
Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombinReto A Schuepbach, Clemens Feistritzer, Lawrence F Brass, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2022
High SARS-CoV-2 vaccination coverage but still room for improvement in patients with haemophila: A single-centre analysisFlorian Kocher, Andreas Seeber, Josia Fauser, et al.
BMC Ophthalmology|May 15, 2022
Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case reportJasmin Regensburger, Teresa Rauchegger, Lorin Loacker, et al.
Therapeutic Advances in Hematology|April 19, 2021
Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical proceduresFlorian Kocher, Andreas Seeber, Johannes Kerschbaumer, et al.
Pageof 7